Project Grant R01EY035494

Award Date 5/1/25
Completion Date 2/28/29
Dollars Obligated $616K
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Detroit, MI 48201, USA
Similar Awards
This federal Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) provides $440,806 to The Research Foundation For The State University Of New York (RF SUNY) to conduct research on the role of the molecular chaperone p58IPK in protecting retinal neurons from damage due to diabetic retinopathy. The 5-year project aims to define the in vivo function of p58IPK in regulating protein and lipid homeostasis in the diabetic retina through the...
This Project Grant award of $442,750 from the National Eye Institute (NEI) under CFDA Program 93.867 "Vision Research" supports research to define a new animal model for studying the pathogenesis of evaporative dry eye disease (EDED). The project aims to (1) characterize the clinical, topographical, and ultrastructural abnormalities of the ocular surface in a mutant mouse model lacking the AWAT2 gene, which is critical for tear film lipid synthesis, and (2) determine the impact of this...
The National Eye Institute (NEI) has awarded a $2,305,702 Project Grant (CFDA 93.867 - Vision Research) to Vanderbilt University Medical Center to conduct integrative multi-omics research to discover molecular pathways associated with diabetic retinopathy (DR). The project aims to quantify differential transcript and metabolite abundance between participants with type 2 diabetes with and without clinical diagnosis of DR in the Cameron County Hispanic Cohort, and replicate findings in the...
This federal Project Grant award from the National Eye Institute (NEI), under CFDA Program 93.867 (Vision Research), provides $107,727 to support research on the molecular mechanisms underlying the role of the protein REDD1 in the development of diabetic retinopathy. The primary objective is to characterize how diabetes causes allosteric regulation of REDD1, leading to increased protein abundance and retinal pathology. The research will employ genetic mouse models and advanced techniques like AI...
This $753,189 Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), aims to identify novel therapeutic targets for corneal epithelial defects. The research will reveal the differential roles of basal epithelial cells in the central cornea, limbus, and conjunctiva in corneal homeostasis and wound repair. Specifically, the study will 1) characterize the heterogeneity of ocular surface basal epithelial cells and the mechanisms...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), supports research to investigate the role of myeloid cell transmigration in the progression of non-proliferative diabetic retinopathy. The project aims to determine whether blocking myeloid cell infiltration can halt inflammation and disease progression in the retina, as well as evaluate the impact of disrupting leukocyte-endothelial interactions on diabetic...
This $176,550 Project Grant awarded by the National Eye Institute (NEI) under CFDA Program 93.867 (Vision Research) supports research to optimize C-MET signaling to enhance corneal epithelial homeostasis. The project aims to determine if inhibiting negative regulation of the C-MET receptor can prolong its activity and accelerate corneal wound healing. The research will involve in vitro studies using immortalized human corneal epithelial cells and in vivo testing in murine corneal wound healing...
This federal Project Grant award, provided by the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), funds research on the role of hyperglycemia and hyperinsulinemia in the breakdown of the blood-retinal barrier in diabetic retinopathy. The $144,362 award, effective September 1, 2024 through February 28, 2027, will support investigations to identify the spatial localization and functions of claudins, tight junction proteins that play a key role in the outer...
The National Eye Institute (NEI) awarded a $184,117 Project Grant (CFDA 93.867 - Vision Research) to Oakland University to investigate the role of G-protein coupled receptors GPR31 and GPR39 in the pathogenesis of diabetic retinopathy. The research aims to determine the affinities and substrate specificities of these receptors for the 12/15-lipoxygenase metabolites 12-HETE and 15-HETE, and to examine the effects of GPR31 and GPR39 gain-or-loss-of-function on retinal endothelial cells and...
The National Eye Institute (NEI) awarded a $581,295 Project Grant (CFDA 93.867 - Vision Research) to the Trustees of Indiana University (IU Indianapolis) to investigate the mechanisms by which corneal nerves regulate limbal stem cell activity for corneal epithelial maintenance and wound healing. The research aims to define the key cellular and molecular regulators that enable corneal Schwann cells to serve as "paracrine factories" supporting the limbal stem cell niche, which is...

This $615,979 Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), supports research to investigate a promising peptide-based combination therapy for restoring structure and function in the diabetic cornea. The key objectives are to: 1) establish the therapeutic role of TB4 and VIP as a combination treatment against diabetes-induced corneal complications; and 2) elucidate the DDR-TRP axis, a novel pathway responsive to hyperglycemic conditions in the cornea. The research approach includes in vitro assessments of corneal epithelial cells and stromal fibroblasts, as well as comprehensive in vivo studies using two mouse models of type 1 diabetes to evaluate changes in corneal structure, function, sensitivity, innervation, inflammation, and wound healing. The research aims to delineate the mechanism of diabetes-induced corneal damage and provide preclinical evidence for developing a novel therapeutic approach with significant translational potential to impact diabetic corneal complications.

Generated 5/13/25, 4:38 AM